JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB153254

Recombinant Human SAMHD1 protein (GST tag N-Terminus)

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human SAMHD1 protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 626 aa range, expressed in Wheat germ, with >80%, suitable for ELISA, WB.

View Alternative Names

MOP5, SAMHD1, Deoxynucleoside triphosphate triphosphohydrolase SAMHD1, dNTPase, Dendritic cell-derived IFNG-induced protein, Monocyte protein 5, SAM domain and HD domain-containing protein 1, DCIP, MOP-5, hSAMHD1

1 Images
SDS-PAGE - Recombinant Human SAMHD1 protein (GST tag N-Terminus) (AB153254)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant Human SAMHD1 protein (GST tag N-Terminus) (AB153254)

ab153254 on a 12.5% SDS-PAGE stained with Coomassie Blue.

Key facts

Purity

>80%

Expression system

Wheat germ

Tags

GST tag N-Terminus

Applications

ELISA, WB

applications

Biologically active

No

Accession

Q9Y3Z3

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 8 Constituents: 0.79% Tris HCl, 0.31% Glutathione

storage-buffer

style
left-column

Complementary Products

Primary Antibodies

AB240199

Anti-SAMHD1 antibody [EPR13040(B)] - BSA and Azide free

RabMAb|Recombinant|KO Validated

Immunocytochemistry/ Immunofluorescence - Anti-SAMHD1 antibody [EPR13040(B)] - BSA and Azide free (AB240199)

  • 0
  • 0
Proteins & Peptides

AB316468

Recombinant Mouse TGF beta Receptor II Protein Standard (His tag)

Sandwich ELISA - Recombinant Mouse TGF beta Receptor II Protein Standard (His tag) (AB316468)

  • 0
  • 0
Proteins & Peptides

AB177656

Recombinant Human AIF protein (His tag N-Terminus)

SDS-PAGE - Recombinant Human AIF protein (His tag N-Terminus) (AB177656)

  • 0
  • 0
Proteins & Peptides

AB268644

Recombinant Human HSF1 protein (Tagged)

SDS-PAGE - Recombinant Human HSF1 protein (Tagged) (AB268644)

  • 0
  • 0
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }
style
left-column
style
left-column

Sequence info

[{"sequence":"MQRADSEQPSKRPRCDDSPRTPSNTPSAEADWSPGLELHPDYKTWGPEQVCSFLRRGGFEEPVLLKNIRENEITGALLPCLDESRFENLGVSSLGERKKLLSYIQRLVQIHVDTMKVINDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","proteinLength":"Full Length","predictedMolecularWeight":"98 kDa","actualMolecularWeight":null,"aminoAcidEnd":626,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Wheat germ","accessionNumber":"Q9Y3Z3","tags":[{"tag":"GST","terminus":"N-Terminus"}]}]
style
left-column

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SAMHD1 also known as Sterile Alpha Motif and HD-Domain Containing Protein 1 functions mechanically as a dGTP-dependent deoxynucleotide triphosphohydrolase. It has a molecular mass of approximately 72 kDa. This protein is expressed in various cell types most notably in immune cells such as macrophages and dendritic cells. SAMHD1 operates by hydrolyzing deoxynucleoside triphosphates (dNTPs) into deoxynucleosides and inorganic triphosphates controlling the intracellular pool of dNTPs.
Biological function summary

SAMHD1 serves as a modulator of cellular proliferation and DNA repair processes. It forms part of a larger complex that regulates DNA replication through its influence on dNTP levels. By modulating these levels the protein prevents excess dNTP buildup which can result in inefficient replication and genomic instability. Moreover SAMHD1 contributes to the innate immune response by restricting viral replication particularly that of retroviruses like HIV-1 in non-dividing cells.

Pathways

SAMHD1 participates in nucleotide metabolism and DNA damage response pathways. For effective dNTP pool regulation it interacts with proteins involved in dNTP synthesis and degradation such as RRM2B. Additionally SAMHD1 is relevant in pathways connected to the restriction of viral infections working alongside proteins like TREX1 that degrade excess DNA and sustain genomic integrity during infection.

SAMHD1 mutations associate with autoimmune disorders and certain types of cancers. Aicardi-Goutières syndrome a rare genetic inflammatory disorder shows links to defective SAMHD1 activity where impaired DNA damage response leads to chronic inflammation. Furthermore altered SAMHD1 expression relates to chronic lymphocytic leukemia where it influences both the proliferation and survival of malignant cells. Interaction with proteins such as DNA-PK is significant in linking SAMHD1 to these conditions demonstrating its role in maintaining immune system balance and genomic stability.
style
left-column

Specifications

Form

Liquid

Additional notes

Glutathione Sepharose

style
left-column

General info

Function

Protein that acts both as a host restriction factor involved in defense response to virus and as a regulator of DNA end resection at stalled replication forks (PubMed : 19525956, PubMed : 21613998, PubMed : 21720370, PubMed : 22056990, PubMed : 23601106, PubMed : 23602554, PubMed : 24336198, PubMed : 26294762, PubMed : 26431200, PubMed : 28229507, PubMed : 28834754, PubMed : 29670289). Has deoxynucleoside triphosphate (dNTPase) activity, which is required to restrict infection by viruses, such as HIV-1 : dNTPase activity reduces cellular dNTP levels to levels too low for retroviral reverse transcription to occur, blocking early-stage virus replication in dendritic and other myeloid cells (PubMed : 19525956, PubMed : 21613998, PubMed : 21720370, PubMed : 22056990, PubMed : 23364794, PubMed : 23601106, PubMed : 23602554, PubMed : 24336198, PubMed : 25038827, PubMed : 26101257, PubMed : 26294762, PubMed : 26431200, PubMed : 28229507). Likewise, suppresses LINE-1 retrotransposon activity (PubMed : 24035396, PubMed : 24217394, PubMed : 29610582). Not able to restrict infection by HIV-2 virus; because restriction activity is counteracted by HIV-2 viral protein Vpx (PubMed : 21613998, PubMed : 21720370). In addition to virus restriction, dNTPase activity acts as a regulator of DNA precursor pools by regulating dNTP pools (PubMed : 23858451). Phosphorylation at Thr-592 acts as a switch to control dNTPase-dependent and -independent functions : it inhibits dNTPase activity and ability to restrict infection by viruses, while it promotes DNA end resection at stalled replication forks (PubMed : 23601106, PubMed : 23602554, PubMed : 29610582, PubMed : 29670289). Functions during S phase at stalled DNA replication forks to promote the resection of gapped or reversed forks : acts by stimulating the exonuclease activity of MRE11, activating the ATR-CHK1 pathway and allowing the forks to restart replication (PubMed : 29670289). Its ability to promote degradation of nascent DNA at stalled replication forks is required to prevent induction of type I interferons, thereby preventing chronic inflammation (PubMed : 27477283, PubMed : 29670289). Ability to promote DNA end resection at stalled replication forks is independent of dNTPase activity (PubMed : 29670289). Enhances immunoglobulin hypermutation in B-lymphocytes by promoting transversion mutation (By similarity).

Sequence similarities

Belongs to the SAMHD1 family.

Post-translational modifications

Phosphorylation at Thr-592 by CDK1 acts as a switch to control deoxynucleoside triphosphate (dNTPase)-dependent and -independent functions (PubMed:29670289). Phosphorylation at Thr-592 takes place in cycling cells: it reduces the stability of the homotetramer, impairing the dNTPase activity and subsequent ability to restrict infection by viruses (PubMed:23601106, PubMed:23602554, PubMed:26294762, PubMed:26431200, PubMed:31291580). It also inhibits ability to suppress LINE-1 retrotransposon activity (PubMed:29610582). In contrast, phosphorylation at Thr-592 promotes DNA end resection at stalled replication forks in response to DNA damage (PubMed:29670289).. (Microbial infection) Phosphorylation at Thr-592 by Epstein-Barr virus kinase BGLF4 and human cytomegalovirus/HCMV UL97 leads to a reduced level of dCTPase and dTTPase activity and the loss of viral restriction.. (Microbial infection) Ubiquitinated following interaction with HIV-2 viral protein Vpx; Vpx promotes interaction and with a DCX (DDB1-CUL4-X-box) E3 ubiquitin ligase, leading to proteasomal degradation.

style
left-column

Product protocols

style
left-column

Target data

Protein that acts both as a host restriction factor involved in defense response to virus and as a regulator of DNA end resection at stalled replication forks (PubMed : 19525956, PubMed : 21613998, PubMed : 21720370, PubMed : 22056990, PubMed : 23601106, PubMed : 23602554, PubMed : 24336198, PubMed : 26294762, PubMed : 26431200, PubMed : 28229507, PubMed : 28834754, PubMed : 29670289). Has deoxynucleoside triphosphate (dNTPase) activity, which is required to restrict infection by viruses, such as HIV-1 : dNTPase activity reduces cellular dNTP levels to levels too low for retroviral reverse transcription to occur, blocking early-stage virus replication in dendritic and other myeloid cells (PubMed : 19525956, PubMed : 21613998, PubMed : 21720370, PubMed : 22056990, PubMed : 23364794, PubMed : 23601106, PubMed : 23602554, PubMed : 24336198, PubMed : 25038827, PubMed : 26101257, PubMed : 26294762, PubMed : 26431200, PubMed : 28229507). Likewise, suppresses LINE-1 retrotransposon activity (PubMed : 24035396, PubMed : 24217394, PubMed : 29610582). Not able to restrict infection by HIV-2 virus; because restriction activity is counteracted by HIV-2 viral protein Vpx (PubMed : 21613998, PubMed : 21720370). In addition to virus restriction, dNTPase activity acts as a regulator of DNA precursor pools by regulating dNTP pools (PubMed : 23858451). Phosphorylation at Thr-592 acts as a switch to control dNTPase-dependent and -independent functions : it inhibits dNTPase activity and ability to restrict infection by viruses, while it promotes DNA end resection at stalled replication forks (PubMed : 23601106, PubMed : 23602554, PubMed : 29610582, PubMed : 29670289). Functions during S phase at stalled DNA replication forks to promote the resection of gapped or reversed forks : acts by stimulating the exonuclease activity of MRE11, activating the ATR-CHK1 pathway and allowing the forks to restart replication (PubMed : 29670289). Its ability to promote degradation of nascent DNA at stalled replication forks is required to prevent induction of type I interferons, thereby preventing chronic inflammation (PubMed : 27477283, PubMed : 29670289). Ability to promote DNA end resection at stalled replication forks is independent of dNTPase activity (PubMed : 29670289). Enhances immunoglobulin hypermutation in B-lymphocytes by promoting transversion mutation (By similarity).
See full target information SAMHD1
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com